MRI Interventions to Report Second Quarter 2013 Financial Results

MEMPHIS, TN -- (Marketwired) -- 08/06/13 -- MRI Interventions, Inc. (OTCQB: MRIC) announced today that it will release its second quarter 2013 financial results on Tuesday, August 13, 2013, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.

What:
MRI Interventions' second quarter 2013 financial results conference call

When:
Tuesday, August 13, 2013, at 4:30 p.m. Eastern Time

Dial In
Number:
877-407-9034 (United States and Canada)

201-493-6737 (International)

Webcast:
A link to the live and replay webcast of the conference call can be found on MRI Interventions' website at https://ir.stockpr.com/mriinterventions/ir-calendar

Call Replay:
A playback of the call will be available through August 20, 2013

Replay
Number:
877-660-6853 (United States and Canada)

201-612-7415 (International)

Conference ID #: 413671

About MRI Interventions, Inc.
Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint® system is designed to enable a wide range of minimally invasive procedures in the brain. MRI Interventions has a co-development and co-distribution agreement with Brainlab, a leader in software-driven medical technology, relating to the ClearPoint system. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. MRI Interventions is also working with Boston Scientific Corporation to incorporate its MRI-safety technologies into Boston Scientific's implantable leads for cardiac and neurological applications. For more information, please visit www.mriinterventions.com.

Contact Information:
MRI Interventions, Inc.
David Carlson
CFO
901-522-9300

Source: MRI Interventions Inc

Released August 6, 2013